Podcasts

Episode 3: Interview with Ron Piervincenzi, CEO of The United States Pharmacopeia

April 7, 2022

Host Jim Fries speaks to Ron Piervincenzi, Ph.D., CEO of the United States Pharmacopeia (USP), in the third episode of The Patient Safety Podcast. The episode covers topics such as Piervincenzi’s time at USP, the […]

Podcasts

Episode 2: Interview with Dr. Janet Woodcock, Principal Deputy Commissioner of the FDA

March 1, 2022

For the second episode of the Patient Safety Podcast, host Jim Fries, CEO of Rx-360, speaks to Dr. Janet Woodcock, Principal Deputy Commissioner of the Food and Drug Administration. Throughout the course of their conversation, […]

Rx-360 Insights

Rx-360 Launches New Podcast: The Patient Safety Podcast

January 19, 2022

Rx-360 has released the first episode of The Patient Safety Podcast, a new series that explores patient safety in the pharmaceutical ecosystem.

Podcasts

Episode 1: Interview with Martin Van Trieste, CEO of Civica Rx

January 17, 2022

Host Jim Fries, CEO of Rx-360, speaks to Martin Van Trieste, president and CEO of Civica Rx in the first episode of the Patient Safety Podcast. Covering topics such as the origin story of Rx-360 […]

Rx-360 Insights

Rx-360 Announces 2022 Board of Directors

December 29, 2021

Rx-360 is pleased to announce their 2022 Board of Directors.

Rx-360 Insights

Rx-360 Launches New Interactive Website

November 24, 2021

Rx-360 has announced the launch of its new website at Rx-360.org.

Rx-360 Insights

Rx-360 Expands Global Initiatives

Rx-360 has announced a broad expansion of its focus on global initiatives that will support its members and their continued efforts in supply chain security.

Events

Pharmaceutical Supply Chain Security

December
6
4 pm UTC+8

On-Demand Webinar
Pharmaceutical Supply Chain Security
In association with
Rx-360
Want to stay in the know of what’s new on the pharmaceutical supply chain security?

Rx-360 Insights

Rx-360 Board of Directors for 2022 (Nomination/Election)

October 27, 2021

Rx-360 has opened up nominations for our 2022 Board of Directors.  The Consortium has one Board seat open.  It is a three year term. 

Publications

Natural Disaster Contingency Planning Version 2.0

October 5, 2021

Rx-360, an International Pharmaceutical Supply Chain Consortium has created this Natural Disaster Contingency Planning guideline in response to natural disasters our members are experiencing. This guideline can serve as a baseline to assist in proactively considering how your organization would internally react in the unfortunate circumstance that a natural disaster impacts one of your business locations.